| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 12/28/2010 | US7858626 Pyrimidineamines as angiogenesis modulators |
| 12/22/2010 | EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors |
| 12/22/2010 | EP1651232B1 Compounds for inflammation and immune-related uses |
| 12/21/2010 | US7855197 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 12/21/2010 | CA2378396C Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
| 12/21/2010 | CA2214406C Use of penciclovir for the treatment of human herpes-virus-8 |
| 12/15/2010 | CN1916009B Process for preparing amine platinum complexes |
| 12/15/2010 | CN1915429B Combinations of the peroxisome proliferator-activated receptor (ppar) activator and sterol absorption inhibitor |
| 12/08/2010 | EP2258848A1 Il-17 homologous polypeptide and therapeutic uses thereof |
| 12/08/2010 | EP2258687A1 Nicotinamide derivates useful as P38 inhibitors |
| 12/02/2010 | US20100305107 Quinoline derivatives and their use as 5-ht6 ligands |
| 12/01/2010 | EP2255798A2 Sphingosine-1-phosphate receptor agonists for use in the treatment of optic neuritis |
| 12/01/2010 | CN1703205B Extended, controlled-release pharmaceutical compositions using charged polymers |
| 12/01/2010 | CN101898982A Npy y5 antagonists |
| 11/30/2010 | CA2430772C Humanized antibodies that recognize beta amyloid peptide |
| 11/18/2010 | US20100292500 Npy y5 antagonist |
| 11/18/2010 | US20100291138 Vaccine |
| 11/17/2010 | EP2251007A2 Sphingosine-1-phosphate (S1P) receptor agonists for use in the treatment of demyelinating diseases |
| 11/16/2010 | CA2429205C Dermatological formulations |
| 11/04/2010 | US20100280075 Paclitaxel enhancer compounds |
| 11/04/2010 | US20100280042 Quinazoline derivatives for the treatment of tumours |
| 11/04/2010 | US20100275913 Composition for inhalation |
| 11/02/2010 | CA2389681C Npy y5 antagonist |
| 10/28/2010 | US20100273817 Anti-cancer cyclopenta(g)quinazoline compounds |
| 10/27/2010 | EP2243484A2 Controlled release oxycodone compositions |
| 10/26/2010 | US7820671 Peptidomimetic protease inhibitors |
| 10/12/2010 | CA2419205C Anti-tnf antibodies, compositions, methods and uses |
| 10/06/2010 | EP1421105B1 Anti-cancer cyclopenta¬g quinazoline compounds |
| 10/06/2010 | EP1296951B1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl in pure crystalline form and process for synthesis |
| 09/29/2010 | EP2233486A1 Azaindoles |
| 09/29/2010 | CN1753673B Prodrugs of GABA analogs, compositions and uses thereof |
| 09/29/2010 | CN101843897A Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 09/28/2010 | CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity |
| 09/21/2010 | US7799774 Quinoline derivatives and their use as 5-HT6 ligands |
| 08/26/2010 | US20100216824 Anti-cancer cyclopenta [G]quinazonline compounds |
| 08/26/2010 | US20100215667 Methods and compositions of treatment for modulating the immune system of animals |
| 08/26/2010 | US20100215661 Nicotinamide derivates useful as p38 inhibitors |
| 08/26/2010 | US20100215652 Nicotinamide derivates useful as p38 inhibitors |
| 08/24/2010 | US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents |
| 08/17/2010 | CA2385269C Novel thiazolo(4,5-d)pyrimidine compounds |
| 08/11/2010 | EP1200106B2 Composition containing extracts of butyrospermum parkii and the use as medicament |
| 08/10/2010 | US7772229 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 08/10/2010 | CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 08/10/2010 | CA2451605C Diamine derivatives |
| 08/05/2010 | US20100197701 Method of treating diabetes |
| 08/04/2010 | CN101792415A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/03/2010 | US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 07/21/2010 | EP1399445B9 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 07/21/2010 | CN1751031B HIV replication inhibiting pyrimidines |
| 07/20/2010 | US7759328 Formeratol and budesonide for treatment of respiratory system disorders such as chronc obstructive pulmonary disease |
| 07/13/2010 | CA2448303C Biologically active methylene blue derivatives |
| 07/08/2010 | US20100173855 Dermatological Formulations |
| 07/06/2010 | US7750042 substituted bis[thio-hydrazide amide] compounds; synergistic effect with taxol or taxotere, anticancer agents, minimal toxic side-effects |
| 06/29/2010 | US7745466 Magnesium salt of S-omeprazole trihydrate of crystal form and another drug such as NSAID, antibiotic, antacid, alginates or prokinetic agents; gastric acid secretion inhibitor, and is useful as an antiulcer agent |
| 06/29/2010 | US7744933 Use of unsaponifiable components of vegetable oils for preparing a cosmetic and related treatments |
| 06/17/2010 | US20100152149 Formulation |
| 06/16/2010 | CN1982308B Substituted pyrazoles |
| 06/16/2010 | CN1829711B Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing them |
| 06/16/2010 | CN101735212A Controlled synthesis of ziprasidone and compositions thereof |
| 06/15/2010 | CA2379103C Novel spiro compounds |
| 06/08/2010 | US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 06/03/2010 | US20100137583 Peptidomimetic protease inhibitors |
| 06/03/2010 | US20100137243 Oxazolidinone And/Or Isoxazoline As Antibacterial Agents |
| 06/03/2010 | US20100136043 Composition comprising immunogenic microparticles |
| 05/26/2010 | CN1744902B Pharmaceutical combination for the treatment of cancer |
| 05/26/2010 | CN1468308B Anti-TNF antibodies, compositions, methods and uses |
| 05/26/2010 | CN1391469B Npyy5拮抗剂 Npyy5 antagonist |
| 05/18/2010 | CA2439475C Carbamate compounds for use in preventing or treating bipolar disorder |
| 05/18/2010 | CA2430508C Condensed purine derivatives as a1 adenosine receptor antagonists |
| 05/13/2010 | US20100120722 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 05/13/2010 | US20100119544 Vaccine |
| 05/12/2010 | EP1564210B9 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 05/12/2010 | CN1426423B Humanized antibodies that sequester amyloid beta peptide |
| 05/11/2010 | CA2442448C Condom with an erectogenic composition |
| 05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 05/04/2010 | US7709479 Quinazoline derivatives and their use as pharmaceuticals |
| 04/29/2010 | US20100105712 Chemical compounds |
| 04/27/2010 | US7705006 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/21/2010 | EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | CN101696232A Peptidomimetic protease inhibitors |
| 04/20/2010 | US7700582 Pharmaceutical formulation |
| 04/20/2010 | CA2410579C Methods and compositions for treating flaviviruses and pestiviruses |
| 04/15/2010 | US20100093785 Diamine derivatives |
| 04/14/2010 | CN101693672A Peptidomimetic protease inhibitors |
| 04/13/2010 | US7696214 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/08/2010 | DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors |
| 04/06/2010 | US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody |
| 04/06/2010 | CA2453383C Piperidine derivatives as nmda receptor antagonists |
| 04/06/2010 | CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/06/2010 | CA2351709C Novel triazolo(4,5-d)pyrimidine compounds |
| 03/30/2010 | CA2374755C Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 03/24/2010 | CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/23/2010 | CA2389767C Quinazoline derivatives as vegf inhibitors |
| 03/18/2010 | US20100069408 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 03/17/2010 | CN101670105A Humanized antibodies chelated with amylord beta peptide |
| 03/16/2010 | CA2566691C Apparatus and method for delivery of therapeutic and/or diagnostic agents |
| 03/10/2010 | EP2161258A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 03/04/2010 | US20100056551 Anti-cancer cyclopenta [G] quinazoline compounds |